M Holdings Securities, Inc. Bei Gene, Ltd. Transaction History

M Holdings Securities, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$189.18 - $286.44 $1.97 Million - $2.98 Million	-10,390 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$107.01 - $175.15 $576,783 - $944,058	5,390 Added 107.8%	10,390 $1.46 Million
Q3 2017 Nov 15, 2017	BUY	$66.19 - $103.46 $330,950 - $517,299	5,000	5,000 $517,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on M Holdings Securities, Inc. with notifications on news.